
Imperagen
Biotech company developing novel drug delivery technologies.
About
Imperagen is a biotechnology company focused on developing innovative drug delivery systems. Their technology aims to improve the efficacy and patient experience of various therapeutic treatments.
Similar companies
Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.
Shares Drug Delivery, Biotech
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- imperagen.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2017
- Total funding
- $7M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 20 May 2026 | Seed | $7M | PXN Ventures |
Tech stack
Detected on imperagen.com, last scanned 6 Nov 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- Lovable
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Imperagen trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Imperagen is 63 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Imperagen raised?
Imperagen has raised a total of $7M in funding. The most recent round on record is Seed.
SEC filings, insider activity, nonprofit links and pay benchmarks for Imperagen:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


